S. Kuroiwa

ANovel Compound , NK 150460 , Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor

K. Nishikawa, S. Horie, Y. Satoh, 2015 .

A Novel Compound, NK150460, Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor

K. Nishikawa, S. Horie, Y. Satoh, 2014, Molecular Cancer Therapeutics.

Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells.

K. Umezawa, T. Takeuchi, M. Hori, 1989, Cancer research.

[The in vitro combination-effect of toremifene with CAF (cyclophosphamide, adriamycin, 5-fluorouracil) on growth of various human mammary carcinomas].

S. Maruyama, F. Abe, M. Okada, 1998, Gan to kagaku ryoho. Cancer & chemotherapy.